Mattson K - National Institutes of Health
Mesothelioma Cancer Expert at National Institutes of Health, Bethesda, MD
Mesothelioma Cancer Expert - Mattson K - Current Listing of Published Papers
The following is a listing of research papers by Mattson K in the field of mesothelioma cancer.
| Knuuttila A, Ollikainen T, Halme M, Mali P, Kivisaari L, Linnainmaa K, Jekunen A, Mattson K. Docetaxel and irinotecan (CPT-11) in the treatment of malignant pleural mesothelioma–a feasibility study. Anticancer Drugs. 2000 Apr;11(4):257-61. Pubmed 10898540 Department of Medicine, Helsinki University Central Hospital, Finland. [hus.fi] |
| Bjorkqvist AM, Wolf M, Nordling S, Tammilehto L, Knuuttila A, Kere J, Mattson K, Knuutila S. Deletions at 14q in malignant mesothelioma detected by microsatellite marker analysis. Br J Cancer. 1999 Dec;81(7):1111-5. Pubmed 10584869 Department of Medical Genetics, Haartman Institute, University Helsinki, Finland. |
| Halme M, Knuuttila A, Vehmas T, Tammilehto L, Mantyla M, Salo J, Mattson K. High-dose methotrexate in combination with interferons in the treatment of malignant pleural mesothelioma. Br J Cancer. 1999 Aug;80(11):1781-5. Pubmed 10468296 Department of Medicine, Helsinki University Central Hospital, Finland. |
| Sahmoud T, Postmus PE, van Pottelsberghe C, Mattson K, Tammilehto L, Splinter TA, Planting AS, Sutedja T, van Pawel J, van Zandwijk N, Baas P, Roozendaal KJ, Schrijver M, Kirkpatrick A, Van Glabbeke M, Ardizzoni A, Giaccone G. Etoposide in malignant pleural mesothelioma: two phase II trials of the EORTC Lung Cancer Cooperative Group. Eur J Cancer. 1997 Nov;33(13):2211-5. Pubmed 9470808 EORTC Data Center, Brussels, Belgium. |
| Tiitola M, Kivisaari L, Huuskonen MS, Mattson K, Koskinen H, Lehtola H, Zitting A, Vehmas T. Computed tomography screening for lung cancer in asbestos-exposed workers. Lung Cancer. 2002 Jan;35(1):17-22. Pubmed 11750708 The Department of Radiology, Helsinki University Central Hospital, Helsinki, Finland. [occuphealth.fi] |
| Pylkkanen L, Sainio M, Ollikainen T, Mattson K, Nordling S, Carpen O, Linnainmaa K, Husgafvel-Pursiainen K. Concurrent LOH at multiple loci in human malignant mesothelioma with preferential loss of NF2 gene region. Oncol Rep. 2002 Sep-Oct;9(5):955-9. Pubmed 12168054 Department of Industrial Hygiene and Toxicology, Finnish Institute of Occupational Health, Helsinki, Finland. |
| Knuuttila A, Kivisaari L, Kivisaari A, Palomaki M, Tervahartiala P, Mattson K. Evaluation of pleural disease using MR and CT. With special reference to malignant pleural mesothelioma. Acta Radiol. 2001 Sep;42(5):502-7. Pubmed 11552888 Department of Medicine, Division of Respiratory Disease, Helsinki University Central Hospital, Helsinki, Finland. |
| Kettunen E, Nissen AM, Ollikainen T, Taavitsainen M, Tapper J, Mattson K, Linnainmaa K, Knuutila S, El-Rifai W. Gene expression profiling of malignant mesothelioma cell lines: cDNA array study. Int J Cancer. 2001 Feb 15;91(4):492-6. Pubmed 11251971 Department of Medical Genetics, Haartman Institute and Helsinki University Central Hospital, University of Helsinki, FIN-00029 HUCH, Helsinki, Finland. |
| Ollikainen T, Knuuttila A, Suhonen S, Taavitsainen M, Jekunen A, Mattson K, Linnainmaa K. In vitro sensitivity of normal human mesothelial and malignant mesothelioma cell lines to four new chemotherapeutic agents. Anticancer Drugs. 2000 Feb;11(2):93-9. Pubmed 10789591 Department of Industrial Hygiene and Toxicology, Finnish Institute of Occupational Health, Helsinki. [occuphealth.fi] |
| Xu L, Flynn BJ, Ungar S, Pass HI, Linnainmaa K, Mattson K, Gerwin BI. Asbestos induction of extended lifespan in normal human mesothelial cells: interindividual susceptibility and SV40 T antigen. Carcinogenesis. 1999 May;20(5):773-83. Pubmed 10334193 Laboratory of Human Carcinogenesis, National Cancer Institute, Bethesda, MD 20892, USA. |
| Hirvonen A, Mattson K, Karjalainen A, Ollikainen T, Tammilehto L, Hovi T, Vainio H, Pass HI, Di Resta I, Carbone M, Linnainmaa K. Simian virus 40 (SV40)-like DNA sequences not detectable in finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines. Mol Carcinog. 1999 Oct;26(2):93-9. Pubmed 10506753 Department of Industrial Hygiene and Toxicology, Finnish Institute of Occupational Health, Helsinki, Finland. |
| Bjorkqvist AM, Tammilehto L, Nordling S, Nurminen M, Anttila S, Mattson K, Knuutila S. Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung. Br J Cancer. 1998;77(2):260-9. Pubmed 9460997 Department of Medical Genetics, Haartman Institute, University of Helsinki, Finland. |
| Knuuttila A, Halme M, Kivisaari L, Kivisaari A, Salo J, Mattson K. The clinical importance of magnetic resonance imaging versus computed tomography in malignant pleural mesothelioma. Lung Cancer. 1998 Dec;22(3):215-25. Pubmed 10048474 Department of Medicine, Helsinki University Central Hospital, Finland. |
| Kahlos K, Anttila S, Asikainen T, Kinnula K, Raivio KO, Mattson K, Linnainmaa K, Kinnula VL. Manganese superoxide dismutase in healthy human pleural mesothelium and in malignant pleural mesothelioma. Am J Respir Cell Mol Biol. 1998 Apr;18(4):570-80. Pubmed 9533946 Department of Internal Medicine, University of Oulu, Oulu, Finland. |
| Holsti LR, Pyrhonen S, Kajanti M, Mantyla M, Mattson K, Maasilta P, Kivisaari L. Altered fractionation of hemithorax irradiation for pleural mesothelioma and failure patterns after treatment. Acta Oncol. 1997;36(4):397-405. Pubmed 9247101 Department of Radiotherapy and Oncology, Helsinki University Central Hospital, Finland. |
| Bjorkqvist AM, Tammilehto L, Anttila S, Mattson K, Knuutila S. Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q and 22q detected by comparative genomic hybridization in malignant mesothelioma. Br J Cancer. 1997;75(4):523-7. Pubmed 9052404 Department of Medical Genetics, Haartman Institute, University of Helsinki, Finland. |
| Karjalainen A, Pukkala E, Mattson K, Tammilehto L, Vainio H. Trends in mesothelioma incidence and occupational mesotheliomas in Finland in 1960-1995. Scand J Work Environ Health. 1997 Aug;23(4):266-70. Pubmed 9322817 Finnish Institute of Occupational Health, Helsinki. |
